Europe Epithelial Cell Culture Media Market is expected to reach US$ 85,845.33 thousand by 2028

The renal epithelial cell segment by product type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Epithelial Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product Type, End User and Country.” The Europe epithelial cell culture media market is expected to reach US$ 85,845.33 thousand by 2028 from US$ 41,737.06 thousand in 2021; it is estimated to grow at a CAGR of 10.9% from 2021 to 2028. The report highlights trends prevailing in the Europe epithelial cell culture media market and the factors driving market along with those that act as hindrances.

The Europe epithelial cell culture media market, by product type, is segmented human mammary epithelial cells, bronchia/trachea epithelial cells, renal epithelial cells, and others. The bronchia/trachea epithelial cells segment held the largest share of the market in 2020, whereas the renal epithelial cell segment is anticipated to register the highest CAGR in the market during the forecast period.

Epithelial cells are valuable in biology research to understand the function of living systems. Extensive funding for supporting the research projects involving the use of epithelial cells to identify new therapeutic solutions for chronic diseases are propelling the demand for epithelial cell culture media. Hence, the increase in such grants for epithelial cell-based research projects are favouring the epithelial cells culture market growth. Also, rapid advancements in the biopharmaceuticals industry are allowing a better understanding of diseases at molecular level. Epithelial cell cultures are widely used in biopharmaceutical and biotechnology industry for drug discovery, drug transport, drug screening and other applications. For instance, researchers in Maastricht University, used respiratory epithelial cells to produce the acute phase protein lipopolysaccharide (LPS)-binding protein (LBP), which plays a fundamental role in the defense to bacterial endotoxins. Thus, the huge presence and vigorous activities in biopharmaceuticals industries in different countries is creating opportunities for research and innovation, further attracting numerous public–private investments, which are creating significant growth opportunities for the epithelial cell culture media market players.

European region is highly affected due to the outbreak of the COVID-19 pandemic. The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. Moreover, the ongoing COVID-19 crisis is likely to put additional pressure on the market to meet the future demand for cell and gene therapies. However, MSD (Merck Sharp & Dohme Corp) in Europe announced COVID-19 vaccine research initiatives in May: a collaboration with IAVI and intentions to purchase Themis Bioscience, a firm that specializes in vaccines and immune-modulation therapies for infectious diseases, including COVID-19. Thus, such initiatives of governments in the region open a window of opportunities for the firms involved in the epithelial cell culture media market.

The growth of the market is attributed to some key driving factors such as rising funds for epithelial cells research and prospering biopharmaceuticals industries in different countries. However, risk of contamination, misidentification, and random alternations in cell lines is expected to obstruct the growth of the market to a certain extent during the forecast years.

Thermo Fisher Scientific Inc., PromoCell GmbH, MERCK KGaA, ATCC, Axol Bioscience Ltd., Celprogen, Inc, Lonza, HiMedia Laboratories, Cell Biologics and BIO-TECHNE CORPORATION are among the leading companies operating in the Europe epithelial cell culture media market.

The report segments in Europe Epithelial Cell Culture Media Market as follows:

By Product Type

• Human Mammary Epithelial Cells
• Bronchia/Trachea Epithelial Cells
• Renal Epithelial Cells
• Others

By End User

• Biopharmaceutical Companies
• Academic and Research Laboratories
• Others

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe